Mode
Text Size
Log in / Sign up

Ependymoma

Part of Glioma

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ependymoma

8 trials tracked for Ependymoma: 1 in phase 3 or 4.

8Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 4 Phase 1 2 Other / NA 1
  1. Phase 3 Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Completed
  2. Phase 2 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) Completed
  3. Phase 2 Carboplatin and Bevacizumab for Recurrent Ependymoma Completed
  4. Phase 2 A Study of Pemetrexed in Children With Recurrent Cancer Completed
  5. Phase 2 Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation Completed
  6. Phase 1 HUMC 1612: Optune NovoTTF-200A System Completed
Show 2 more trials
  1. Phase 1 Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children Completed
  2. N/A Molecular-Guided Therapy for Childhood Cancer Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.